Stay updated on Patisiran for hATTR Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Patisiran for hATTR Amyloidosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces the NIH transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T12:37:09.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:27:33.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:26:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, with the error document structure added (doctype, metadata, title). A minimal header/footer remains, and many related links and terms have been removed from the page.
    Difference
    14%
    Check dated 2026-09-28T19:04:59.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.5 to v3.6.6, indicating a new software version of the page. This update appears to be a backend/UI refresh and does not modify study content or data presented.
    Difference
    0.1%
    Check dated 2026-08-31T16:49:23.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The study page now displays an error page instead of the trial content, indicating the record is unavailable; the previous study details have been replaced by the error HTML.
    Difference
    14%
    Check dated 2026-08-10T10:53:39.000Z thumbnail image

Stay in the know with updates to Patisiran for hATTR Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Patisiran for hATTR Amyloidosis Clinical Trial page.